Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Perrigo acquires generic Retin-A portfolio from Matawan Pharmaceuticals Perrigo has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals.
Production & Manufacturing > OTC > News
Perrigo to buy Retin-A portfolio from Matawan Pharmaceuticals Perrigo will acquire a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals.
Production & Manufacturing > OTC > News AstraZeneca completes deal with Perrigo for rights to Entocort in US AstraZeneca has completed its agreement with Perrigo Company for the divestment of US rights to Entocort (budesonide), a gastroenterology medicine for patients with mild to moderate Crohn’s disease, an area of medicine outside AstraZeneca’s strategic focus.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Vanc Pharmaceuticals launches first OTC product in British Columbia
Vanc Pharmaceuticals has commercialized its first OTC products in British Columbia: Cortivera and Cortivera Plus for a wide range of minor skin irritations, allergic reactions and eczema.
Production & Manufacturing > OTC > News
Sinclair IS Pharma to sell non-aesthetics business to Alliance Pharma
By PBR Staff Writer
Sinclair IS Pharma has agreed to sell its non-aesthetics business to Alliance Pharma for £132m.
Production & Manufacturing > OTC > News
FDA takes action to protect consumers from potential dangerous dietary supplements
The US Food and Drug Administration, in partnership with other government agencies, announced the results of a yearlong sweep of dietary supplements to identify potentially unsafe or tainted supplements.
Production & Manufacturing > OTC > News
Perrigo shareholders reject Mylan's $26bn takeover bid
By PBR Staff Writer
Perrigo shareholders have rejected a hostile, $26bn takeover bid from Mylan.
Production & Manufacturing > OTC > News
LEO Pharma to buy Astellas Pharma's global dermatology portfolio
By PBR Staff Writer
LEO Pharma has agreed to acquire Astellas Pharma's global dermatology business for €675m.
Production & Manufacturing > OTC > News
Nitrosolution releases new nitroxyl performance supplement
Nitrosolution, a provider of nitric oxide supplements, has released a new product called Nitroxyl Performance.
Production & Manufacturing > OTC > News
Piramal Enterprises buys baby-care brand, Little’s
Piramal Enterprises’ Consumer Products Division announces the acquisition of the baby-care brand “Little’s”, which includes the entire product range across six categories.
Production & Manufacturing > OTC > News
US FTC clears Mylan's proposed acquisition of Perrigo
By PBR Staff Writer
The US Federal Trade Commission (FTC) has cleared Mylan's proposed transaction to acquire Perrigo.
Production & Manufacturing > OTC > News
Study says people could be risking health by incorrectly mixing different kinds of OTC medications
Millions of people could be risking their health by inappropriately mixing different kinds of over-the-counter (OTC) medications, according to a new study co-authored by a Sacramento State professor.
Production & Manufacturing > OTC > News
Conception Kit at-home system launches product
The Conception Kit at-home system from Conceivex is a comprehensive fertility treatment enabling couples to determine the optimal time to get pregnant and includes an innovative cervical cap protecting and concentrating semen around the cervical opening to increase the chances for sperm to penetrate the cervix to fertilize the egg.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests